UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF
1934
For the month of August 2012
Commission File Number: 001-34225
VIMICRO
INTERNATIONAL CORPORATION
15/F Shining Tower
No. 35 Xueyuan Road, Haidian District
Beijing 100191, Peoples
Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F
x
Form
40-F
¨
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
This Form 6-K is being incorporated by reference into the registrants Registration Statement on Form S-3 (File No. 333-166948), filed with the Securities and Exchange Commission on May 19,
2010.
Second-Quarter 2012 Results
Vimicro International Corporation (Vimicro or the Company) reports its unaudited financial results for the second quarter ended June 30, 2012.
Net revenue in the second quarter of 2012 was $20.1 million, as compared to a net revenue of $11.6 million in the first quarter of 2012 and $14.2 million
from continuing operations in the second quarter of 2011. The 41.8% year-over-year revenue increase was driven by the growth in sales of both PC-camera processors and surveillance solutions.
Gross profit in the second quarter of 2012 was $6.9 million, as compared to $4.8 million in the second quarter of 2011. The gross margin in the second quarter of 2012 was 34.1%, compared with 33.5% in the
second quarter of 2011 and 30.6% in the first quarter of 2012. The increase in gross margin reflected a more favorable product mix.
Operating
expenses in the second quarter of 2012 were $8.5 million, as compared to $12.3 million in the second quarter of 2011. The year-over-year decrease in operating expenses reflected the Companys restructuring efforts and cost-control initiatives.
The operating loss was $1.6 million in the second quarter of 2012, compared to $7.5 million in the second quarter of 2011.
The Companys
non-GAAP net income attributable to Vimicro was $729,000, or approximately $0.02 per ADS on a diluted basis in the second quarter of 2012, as compared to a non-GAAP net loss attributable to Vimicro of $5.6 million, or $0.09 per ADS from continuing
operations in the second quarter of 2011. The non-GAAP net income attributable to Vimicro reflected an adjustment for exclusion of $1.1 million in non-cash, share-based compensation.
The Company recorded positive cash flow from operations of $4.7 million in the second quarter of 2012. As of June 30, 2012, the Company had cash and cash equivalents of approximately $35.5 million,
held-to-maturity securities of $4.0 million and restricted cash of $6.3 million, totaling $45.8 million. Vimicro had a total current assets of approximately $92.5 million, a working capital of approximately $61.7 million and long-term bank loans of
$4.7 million recorded on its balance sheet as of June 30, 2012.
Non-GAAP Measures
To supplement the consolidated financial statements presented in accordance with GAAP, Vimicro uses non-GAAP measures of non-GAAP income/(loss) from operations, non-GAAP net income/(loss) attributed to
Vimicro International Corporation and non-GAAP diluted net income /(loss) per ADS, which are adjusted from the most directly comparable financial measures calculated and presented in accordance with GAAP to exclude amortization of share-based
compensation expense. These non-GAAP financial measures are provided to enhance investors overall understanding of the companys financial performance as they exclude share-based expenses that are not expected to result in future cash
payments. The non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. A limitation of using these non-GAAP financial measures is that
these non-GAAP measures exclude share-based compensation charges that have been and will continue to be significant recurring expenses in our business for the foreseeable future. We compensate for these limitations by providing the relevant
disclosure of our share-based compensation charges in our reconciliations to the GAAP measures. For more information on the non-GAAP financial measures, please see the tables captioned Reconciliation of non-GAAP results of operations measures
to the nearest comparable GAAP measures set forth at the end of this release.
Vimicro believes that both management and investors
benefit from referring to these non-GAAP measures in assessing the performance of Vimicros liquidity and when planning and forecasting future periods. These non-GAAP financial measures also facilitate managements internal comparisons to
Vimicros historical liquidity. Vimicro computes its non-GAAP financial measures using the same consistent method from quarter to quarter. The accompanying tables have more details on the GAAP financial measures that are most comparable to
non-GAAP financial measures and the related reconciliations between financial measures.
Currency Translation
This announcement contains translations of certain RMB amounts into U.S. dollars. Unless otherwise noted, all translations from RMB to U.S. dollars are
based on the applicable exchange rates quoted by the Bank of China on June 29, 2012, which was RMB 6.3249 to $1.00.
Vimicro International Corporation
Consolidated Balance Sheets
(Amounts expressed in thousands of U.S. dollars, except number of share data)
|
|
|
|
|
|
|
|
|
|
|
6/30/2012
|
|
|
12/31/2011
|
|
|
|
(unaudited)
|
|
|
(audited)
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
35,536
|
|
|
$
|
49,227
|
|
Restricted cash
|
|
|
6,275
|
|
|
|
3,520
|
|
Held-to-maturity
|
|
|
3,953
|
|
|
|
0
|
|
Accounts and notes receivable, net of provision for doubtful accounts of $1,822 and $2,340 as of December 31, 2011 and
June 30, 2012, respectively
|
|
|
20,445
|
|
|
|
17,895
|
|
Amounts due from related party
|
|
|
4,559
|
|
|
|
4,831
|
|
Inventories
|
|
|
18,265
|
|
|
|
18,734
|
|
Prepayments and other current assets, net of provision for doubtful accounts of $162 and $180 as of December 31, 2011 and
June 30, 2012, respectively
|
|
|
3,129
|
|
|
|
4,057
|
|
Deferred tax assets
|
|
|
357
|
|
|
|
356
|
|
Total current assets
|
|
|
92,519
|
|
|
|
98,620
|
|
Investment in an unconsolidated affiliate
|
|
|
1,514
|
|
|
|
1,520
|
|
Property, equipment and software, net
|
|
|
14,826
|
|
|
|
14,266
|
|
Land use rights
|
|
|
21,254
|
|
|
|
21,488
|
|
Deferred tax assets-non current
|
|
|
112
|
|
|
|
112
|
|
Other assets
|
|
|
1,238
|
|
|
|
1,291
|
|
Total assets
|
|
|
131,463
|
|
|
|
137,297
|
|
|
|
|
Liabilities and Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
7,984
|
|
|
|
9,280
|
|
Notes payable
|
|
|
485
|
|
|
|
1,013
|
|
Amounts due to related party
|
|
|
1,447
|
|
|
|
963
|
|
Taxes payable
|
|
|
2,053
|
|
|
|
1,209
|
|
Advances from customers
|
|
|
2,405
|
|
|
|
1,916
|
|
Accrued expenses and other current liabilities
|
|
|
7,162
|
|
|
|
8,333
|
|
Deferred government grant
|
|
|
9,264
|
|
|
|
5,910
|
|
Total current liabilities
|
|
|
30,800
|
|
|
|
28,624
|
|
Non-Current liabilities:
|
|
|
|
|
|
|
|
|
Deferred tax liabilities
|
|
|
33
|
|
|
|
33
|
|
Product warranty
|
|
|
386
|
|
|
|
300
|
|
Long-term bank loan
|
|
|
4,743
|
|
|
|
0
|
|
Total liabilities
|
|
|
35,962
|
|
|
|
28,957
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
|
|
Ordinary shares,$0.0001 par value, 500,000,000 shares authorized, 139,953,296 and 118,889,892 shares issued and outstanding as of
December 31, 2011 and June 30, 2012, respectively
|
|
|
15
|
|
|
|
15
|
|
Additional paid-in capital
|
|
|
160,131
|
|
|
|
158,879
|
|
Treasury stock
|
|
|
(13,077
|
)
|
|
|
(6,490
|
)
|
Accumulated other comprehensive income
|
|
|
12,688
|
|
|
|
12,850
|
|
Accumulated deficit
|
|
|
(86,649
|
)
|
|
|
(82,630
|
)
|
Statutory reserve
|
|
|
2,782
|
|
|
|
2,782
|
|
Total shareholders equity attributable to Vimicro International Corporation
|
|
|
75,890
|
|
|
|
85,406
|
|
Non-controlling interest
|
|
|
19,611
|
|
|
|
22,934
|
|
Total shareholders equity
|
|
|
95,501
|
|
|
|
108,340
|
|
|
|
|
Total liabilities and shareholders equity
|
|
|
131,463
|
|
|
|
137,297
|
|
Vimicro International Corporation
Consolidated Statement of Comprehensive Loss
(Amounts expressed in thousands of U.S. dollars, except number of shares and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 Q2
|
|
|
2012 Q1
|
|
|
2011 Q2
|
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
|
|
|
|
Net revenue
|
|
|
20,140
|
|
|
|
11,570
|
|
|
|
14,200
|
|
|
|
|
|
Cost of revenue
|
|
|
(13,275
|
)
|
|
|
(8,027
|
)
|
|
|
(9,437
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
6,865
|
|
|
|
3,543
|
|
|
|
4,763
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development, net
|
|
|
(3,052
|
)
|
|
|
(3,482
|
)
|
|
|
(5,676
|
)
|
Selling and marketing
|
|
|
(2,348
|
)
|
|
|
(2,476
|
)
|
|
|
(3,681
|
)
|
General and administrative
|
|
|
(3,097
|
)
|
|
|
(3,041
|
)
|
|
|
(2,953
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
(8,497
|
)
|
|
|
(8,999
|
)
|
|
|
(12,310
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(1,632
|
)
|
|
|
(5,456
|
)
|
|
|
(7,547
|
)
|
|
|
|
|
Other income:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
125
|
|
|
|
90
|
|
|
|
165
|
|
Foreign exchange gain/(loss), net
|
|
|
(159
|
)
|
|
|
36
|
|
|
|
447
|
|
Gain on disposal of marketable equity securities
|
|
|
0
|
|
|
|
0
|
|
|
|
632
|
|
Others, net
|
|
|
1
|
|
|
|
1
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes and share of profit of an unconsolidated affiliate
|
|
|
(1,665
|
)
|
|
|
(5,329
|
)
|
|
|
(6,288
|
)
|
|
|
|
|
Income taxes expense
|
|
|
(175
|
)
|
|
|
(194
|
)
|
|
|
(53
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss before share of profit of an unconsolidated affiliate
|
|
|
(1,840
|
)
|
|
|
(5,523
|
)
|
|
|
(6,341
|
)
|
|
|
|
|
Net loss from continuing operations
|
|
|
(1,840
|
)
|
|
|
(5,523
|
)
|
|
|
(6,341
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, net of income tax
|
|
|
0
|
|
|
|
0
|
|
|
|
(2,230
|
)
|
|
|
|
|
Net loss
|
|
|
(1,840
|
)
|
|
|
(5,523
|
)
|
|
|
(8,571
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss attributable to non-controlling interest
|
|
|
(1,497
|
)
|
|
|
(1,847
|
)
|
|
|
(2,268
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss attributed to Vimicro International Corporation
|
|
|
(343
|
)
|
|
|
(3,676
|
)
|
|
|
(6,303
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share - basic and diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
continuing operations
|
|
|
(0.00
|
)
|
|
|
(0.03
|
)
|
|
|
(0.02
|
)
|
discontinued operations
|
|
|
0.00
|
|
|
|
0.00
|
|
|
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share- basic and diluted
|
|
|
(0.00
|
)
|
|
|
(0.03
|
)
|
|
|
(0.04
|
)
|
|
|
|
|
Loss per ADS Basic and Diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
continuing operations
|
|
|
(0.01
|
)
|
|
|
(0.11
|
)
|
|
|
(0.11
|
)
|
discontinued operations
|
|
|
0.00
|
|
|
|
0.00
|
|
|
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per ADS- basic and diluted
|
|
|
(0.01
|
)
|
|
|
(0.11
|
)
|
|
|
(0.17
|
)
|
|
|
|
|
Weighted average number of ordinary shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted
|
|
|
121,877,701
|
|
|
|
134,898,768
|
|
|
|
146,820,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ADS outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted
|
|
|
30,469,425
|
|
|
|
33,724,692
|
|
|
|
36,705,198
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income/(loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment
|
|
|
(175
|
)
|
|
|
36
|
|
|
|
867
|
|
Unrealized loss on marketable equity securities
|
|
|
0
|
|
|
|
0
|
|
|
|
(550
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
|
(2,015
|
)
|
|
|
(5,487
|
)
|
|
|
(8,254
|
)
|
Comprehensive loss attributable to non-controlling interest
|
|
|
(1,498
|
)
|
|
|
(1,826
|
)
|
|
|
(1,866
|
)
|
Comprehensive loss attributable to Vimicro International Corporation
|
|
|
(517
|
)
|
|
|
(3,661
|
)
|
|
|
(6,388
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of share-based compensation expenses are included in the following expense captions:
|
|
|
|
|
|
|
|
|
|
|
|
|
R&D
|
|
|
(462
|
)
|
|
|
(83
|
)
|
|
|
(197
|
)
|
S&M
|
|
|
(50
|
)
|
|
|
(20
|
)
|
|
|
(27
|
)
|
G&A
|
|
|
(560
|
)
|
|
|
(77
|
)
|
|
|
(474
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
(1,072
|
)
|
|
|
(180
|
)
|
|
|
(698
|
)
|
Reconciliations of non-GAAP results of operations measures to the nearest comparable GAAP
measures (*)
(Amounts expressed in thousands of U.S. dollars, except number of shares and per share data, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
June 30, 2012
|
|
|
Three months ended
March 31, 2012
|
|
|
Three months ended
June 30, 2011
|
|
|
|
GAAP
Result
|
|
|
Adjustment
|
|
|
Non-
GAAP
Result
|
|
|
GAAP
Result
|
|
|
Adjustment
|
|
|
Non-
GAAP
Result
|
|
|
GAAP
Result
|
|
|
Adjustment
|
|
|
Non-
GAAP
Result
|
|
Loss from operations
|
|
$
|
(1,632
|
)
|
|
$
|
1,072
|
|
|
$
|
(560
|
)
|
|
$
|
(5,456
|
)
|
|
$
|
180
|
|
|
$
|
(5,276
|
)
|
|
$
|
(7,547
|
)
|
|
$
|
698
|
|
|
$
|
(6,849
|
)
|
Income/(loss) attributed to Vimicro International Corporation
|
|
|
(343
|
)
|
|
|
1,072
|
|
|
|
729
|
|
|
|
(3,676
|
)
|
|
|
180
|
|
|
|
(3,496
|
)
|
|
|
(6,303
|
)
|
|
|
698
|
|
|
|
(5,605
|
)
|
Income/(loss) from continuing operations per ADS(**)
|
|
|
(0.01
|
)
|
|
|
0.03
|
|
|
|
0.02
|
|
|
|
(0.11
|
)
|
|
|
0.01
|
|
|
|
(0.10
|
)
|
|
|
(0.11
|
)
|
|
|
0.02
|
|
|
|
(0.09
|
)
|
(*)
|
The adjustment is to exclude non-cash share-based compensation for employees and non-employees.
|
(**)
|
Loss per ADS refers to continuing operations
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
VIMICRO INTERNATIONAL CORPORATION
|
|
|
By:
|
|
/s/ John Zhonghan Deng
|
Name:
|
|
John Zhonghan Deng
|
Title:
|
|
Chairman and Chief Executive Officer
|
Date: August 10, 2012
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024